| 英文别名 |
Takeda103A;N-(2,6-Difluorobenzyl)-3-({[4-Propyl-5-(Pyrimidin-4-Yl)-4h-1,2,4-Triazol-3-Yl]methyl}amino)benzamide;N-[(2,6-Difluorophenyl)methyl]-3-[[[4-propyl-5-(4-pyrimidinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-benzamide;3pvw;N-(2,6-Difluorobenzyl)-3-(((4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)methyl)amino)benzamide;BDBM50173313;Q27464782;N-[(2,6-difluorophenyl)methyl]-3-[(4-propyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)methylamino]benzami;Benzamide, N-[(2,6-difluorophenyl)methyl]-3-[[[4-propyl-5-(4-pyrimidinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-;CMPD103A;CMPD-103A;Inhibitor,inhibit,heart failure,GRK2,Takeda103A,GPCRs;N-[(2,6-Difluorophenyl)methyl]-3-[[[4-propyl-5-(4pyrimidinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]benzamid;CHEMBL1738878;MS-28527;AKOS040746389;AC-36676;865609-72-9;CS-0103707;N-[(2,6-difluorophenyl)methyl]-3-({[4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl]methyl}amino)benzamide;QRX;SCHEMBL19272607;N-[(2,6-difluorophenyl)methyl]-3-[(4-propyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)methylamino]benzamide;EX-A4860;HY-129118;N-[(2,6-difluorophenyl)methyl]-3-({[4-propyl-5-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]methyl}amino)benzamide;G90347;Takeda103A?;DA-67905 |